Search research articles
Contact Us
Filters
Showing results (251-260 of 302) with videos related to
Page
of 31
Sort By:
Molecular & Cellular Proteomics : MCP
|
February 27, 2017
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals
Kyle C Arend, Erik M Lenarcic, Heather A Vincent, et al.
Science Advances
|
October 26, 2022
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency
Amanda B Wass, Benjamin A Krishna, Laura E Herring, et al.
Child Abuse & Neglect
|
November 22, 2023
Parental absence as an adverse childhood experience among young adults in sub-Saharan Africa
Francis B Annor, Ermias W Amene, Liping Zhu, et al.
Cancer Research Communications
|
November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
Yoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Nature Immunology
|
January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
Feifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
Neuro-Oncology
|
July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
Steven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Science Signaling
|
July 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
Devon R Blake, Angelina V Vaseva, Richard G Hodge, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth
Linas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 302) with videos related to
Sort By:
Page
of 31
Molecular & Cellular Proteomics : MCP
|
February 27, 2017
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals
Kyle C Arend, Erik M Lenarcic, Heather A Vincent, et al.
Science Advances
|
October 26, 2022
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency
Amanda B Wass, Benjamin A Krishna, Laura E Herring, et al.
Child Abuse & Neglect
|
November 22, 2023
Parental absence as an adverse childhood experience among young adults in sub-Saharan Africa
Francis B Annor, Ermias W Amene, Liping Zhu, et al.
Cancer Research Communications
|
November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis
Yoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Nature Immunology
|
January 8, 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
Feifei Song, Ourania Tsahouridis, Simone Stucchi, et al.
Neuro-Oncology
|
July 9, 2018
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma
Steven P Angus, Janet L Oblinger, Timothy J Stuhlmiller, et al.
Science Signaling
|
July 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
Devon R Blake, Angelina V Vaseva, Richard G Hodge, et al.
ACS Chemical Biology
|
April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues
Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth
Linas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
The Journal of Biological Chemistry
|
October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
J Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Page
of 31